Oncology Institute (TOI) Competitors $2.16 +0.22 (+11.34%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.21 +0.05 (+2.13%) As of 04/17/2025 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI vs. INNV, EHAB, SBC, CELC, PSNL, VMD, DCGO, LFMD, CORBF, and SERAShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include InnovAge (INNV), Enhabit (EHAB), SBC Medical Group (SBC), Celcuity (CELC), Personalis (PSNL), Viemed Healthcare (VMD), DocGo (DCGO), LifeMD (LFMD), Global Cord Blood (CORBF), and Sera Prognostics (SERA). These companies are all part of the "healthcare" industry. Oncology Institute vs. InnovAge Enhabit SBC Medical Group Celcuity Personalis Viemed Healthcare DocGo LifeMD Global Cord Blood Sera Prognostics Oncology Institute (NASDAQ:TOI) and InnovAge (NASDAQ:INNV) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, community ranking, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings. Does the MarketBeat Community favor TOI or INNV? Oncology Institute received 4 more outperform votes than InnovAge when rated by MarketBeat users. Likewise, 66.67% of users gave Oncology Institute an outperform vote while only 0.00% of users gave InnovAge an outperform vote. CompanyUnderperformOutperformOncology InstituteOutperform Votes466.67% Underperform Votes233.33% InnovAgeOutperform VotesNo VotesUnderperform Votes5100.00% Which has stronger valuation and earnings, TOI or INNV? InnovAge has higher revenue and earnings than Oncology Institute. InnovAge is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$393.41M0.41-$83.07M-$0.71-3.04InnovAge$806.61M0.46-$21.34M-$0.19-14.47 Do analysts rate TOI or INNV? InnovAge has a consensus price target of $5.00, suggesting a potential upside of 81.82%. Given InnovAge's stronger consensus rating and higher possible upside, analysts clearly believe InnovAge is more favorable than Oncology Institute.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InnovAge 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Does the media favor TOI or INNV? In the previous week, InnovAge had 2 more articles in the media than Oncology Institute. MarketBeat recorded 3 mentions for InnovAge and 1 mentions for Oncology Institute. InnovAge's average media sentiment score of 0.33 beat Oncology Institute's score of 0.00 indicating that InnovAge is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InnovAge 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals have more ownership in TOI or INNV? 36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 12.3% of InnovAge shares are owned by institutional investors. 9.5% of Oncology Institute shares are owned by company insiders. Comparatively, 1.4% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, TOI or INNV? Oncology Institute has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500. Comparatively, InnovAge has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Is TOI or INNV more profitable? InnovAge has a net margin of -3.19% compared to Oncology Institute's net margin of -17.63%. InnovAge's return on equity of -9.45% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-17.63% -186.83% -34.58% InnovAge -3.19%-9.45%-4.84% SummaryInnovAge beats Oncology Institute on 12 of the 17 factors compared between the two stocks. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$163.21M$969.81M$5.30B$7.35BDividend YieldN/AN/A5.12%4.30%P/E Ratio-2.7715.9921.8017.80Price / Sales0.411.05379.9697.74Price / CashN/A36.0138.2634.64Price / Book2.818.296.443.98Net Income-$83.07M-$52.07M$3.21B$247.73M7 Day Performance20.67%2.15%2.87%1.81%1 Month Performance160.96%10.88%-8.63%-6.98%1 Year Performance75.61%-7.88%11.46%1.37% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute0.2063 of 5 stars$2.16+11.3%N/A+84.6%$163.21M$393.41M-2.77660INNVInnovAge1.5852 of 5 stars$3.04+7.4%$5.00+64.5%-31.3%$411.14M$806.61M-16.002,000Short Interest ↓News CoverageEHABEnhabit2.0754 of 5 stars$7.93-2.8%$8.50+7.3%-24.5%$400.05M$1.03B-3.4210,800News CoveragePositive NewsSBCSBC Medical GroupN/A$3.40+3.3%N/AN/A$350.27M$205.42M0.00N/ACELCCelcuity1.3255 of 5 stars$9.16+5.9%$30.17+229.3%-39.8%$346.61MN/A-3.5140High Trading VolumePSNLPersonalis3.4198 of 5 stars$3.25+4.5%$7.80+140.0%+165.8%$286.86M$84.61M-1.93400News CoverageVMDViemed Healthcare0.9965 of 5 stars$6.61-3.9%N/A-15.2%$261.24M$224.26M24.48630Short Interest ↑News CoverageDCGODocGo3.1457 of 5 stars$2.54+1.2%$4.89+92.6%-36.9%$259.04M$616.56M9.072,920News CoveragePositive NewsLFMDLifeMD2.4626 of 5 stars$4.95-4.1%$11.43+130.9%-45.0%$220.69M$212.45M-7.73230News CoveragePositive NewsCORBFGlobal Cord BloodN/A$1.15flatN/A-48.0%$139.78M$196.12M0.001,200SERASera Prognostics0.3027 of 5 stars$3.39+6.3%N/A-64.9%$127.68M$77,000.00-3.42120 Related Companies and Tools Related Companies InnovAge Alternatives Enhabit Alternatives SBC Medical Group Alternatives Celcuity Alternatives Personalis Alternatives Viemed Healthcare Alternatives DocGo Alternatives LifeMD Alternatives Global Cord Blood Alternatives Sera Prognostics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TOI) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TOI Stock Free TOI Stock Alerts